关于分子时代质瘤管理的最新信息
Ali Ahmed Mohamed1, Rakan Alshaibi2, Steven Faragalla1
1Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL 33431, United States.
World journal of clinical oncology
|March 8, 2024
概括
本综述探讨了当前2023年成人和儿童的结质瘤治疗方法,重点是手术,化疗和放射治疗. 它强调为儿科质瘤和分子亚型 (如异酸脱酶突变天体细胞瘤) 量身定制的方法.
科学领域:
- 神经瘤学神经瘤学
- 癌症治疗方法 癌症治疗方法
- 分子病理学分子病理学
背景情况:
- 质瘤是原发性脑瘤,影响成人和儿童,其特征各异.
- 最近分子分类和预后因素的进步正在重塑治疗策略.
- 了解质瘤异质性对于有效的治疗干预至关重要.
研究的目的:
- 审查当前 (2023) 成人和儿科质瘤的治疗方法.
- 讨论基于质瘤等级和分子分类的治疗方法.
- 确定有关特定质瘤亚型和儿科队列的知识差距.
主要方法:
- 对当前临床和分子预后因素的文献综述.
- 分析已建立的治疗模式,包括手术,化疗和放射治疗.
- 检查化学疗法方案,如温克里斯,碳白和温布拉斯.
主要成果:
- 成人质瘤治疗通常包括手术,化疗和放射治疗.
- 儿科质瘤需要个性化治疗计划,包括非切除病例的化疗.
- 当初始治疗失败时,使用诸如温克里斯/卡博普拉和温布拉之类的特殊疗法.
结论:
- 目前的质瘤治疗越来越多地根据分子分类和患者年龄量身定制.
- 需要对异酸脱酶突变天体细胞瘤和儿科质瘤治疗进行进一步的研究.
- 优化治疗需要对新的治疗方法进行持续的研究.
相关概念视频
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.